(AOF) – The Equasens group recorded a turnover of 53.3 million euros in the 1st quarter, down 5.2% compared to the 1st quarter of 2023, but up slightly compared to the 4th quarter of 2023 (- 5.5%). The group specializing in healthcare software solutions intends to return to growth from the second half of the year after a strong investment phase. It expects “a slight recovery in growth from the second half of 2024, followed by a significant acceleration from 2025”.
“This perspective is based on its confidence in the resilience of healthcare professionals in the face of current challenges and in their ability to reinvest very quickly,” specifies the company.
Equasens “continues its investments in order to offer new innovative offers to healthcare professionals by favoring SaaS mode”, and “remains open to external growth opportunities in line with its strategy based on interoperability between healthcare professionals and their patients and strengthening its presence in Europe.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
